Artelo Biosciences, Inc.
ARTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20,498 | $24,864 | $8,184 | $17,019 |
| - Cash | $2,338 | $2,815 | $6,888 | $6,629 |
| + Debt | $104 | $23 | $63 | $95 |
| Enterprise Value | $18,264 | $22,072 | $1,359 | $10,485 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,108 | -$9,930 | -$10,078 | -$7,437 |
| % Margin | – | – | – | – |
| Net Income | -$9,826 | -$9,289 | -$10,083 | -$7,437 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.05 | -3.14 | -3.49 | -5.97 |
| % Growth | 2.9% | 10% | 41.5% | – |
| Operating Cash Flow | -$8,350 | -$8,207 | -$8,008 | -$6,141 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8,350 | -$8,207 | -$8,008 | -$6,141 |